(11aR)-3,7-双(3,5-二甲基苯基)-10,11,12,13-四氢-5-羟基-5-氧化物二茚并[7,1-de:1',7'-fg][1,3,2]二氧磷杂八环，min. 98%

(11aR)-3,7-Bis(3,5-dimethylphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, min. 98%

仅供研发或工业应用，不可直接用于食品、药品、临床诊断或治疗。